Related Experiment Video
Updated: Mar 17, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside
Golukhova E Z1, Gromova O I1, Shomahov R A1
1Bakoulev Centre for Cardiovascular Surgery, Rublevskoye sh. 135, 121552, Moscow, Russia.
Insights
Sudden cardiac death (SCD) is a fatal syndrome caused by heart rhythm disorders. This review explores the molecular and genetic basis of various SCD types and prevention strategies.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Sudden cardiac death (SCD) is the abrupt loss of cardiac function, often due to arrhythmias, causing unexpected death.
- While coronary artery disease increases SCD risk with age, a notable incidence peak occurs below age 5 due to congenital arrhythmic canalopathies.
- Ventricular tachyarrhythmias like VT and VF are primary causes of SCD, with bradyarrhythmias and PEA being less common immediate triggers.
Purpose of the Study:
- To review the molecular and genetic underpinnings of various sudden cardiac death syndromes.
- To discuss current understanding of SCD mechanisms, from ion channel physiology to monogenic disorders.
- To outline modern prevention strategies for sudden cardiac death.
Main Methods:
- Literature review of basic science investigations into cardiac electrophysiology and molecular genetics.
- Analysis of molecular and genetic basis for specific SCD conditions.
- Overview of contemporary SCD prevention techniques.
Main Results:
- Identified congenital monogenic arrhythmic canalopathies as a cause for SCD in young children.
- Detailed the role of ventricular tachyarrhythmias as the primary mechanism of SCD.
- Highlighted the contribution of ion channel dysfunction and genetic mutations to inherited arrhythmia syndromes.
Conclusions:
- Understanding the molecular and genetic basis of SCD is crucial for developing effective prevention strategies.
- Specific syndromes like Long QT syndrome, Brugada syndrome, and others share common molecular pathways.
- Modern interventions, including implantable cardioverter-defibrillators, offer improved prevention for at-risk individuals.
Abstract:
The abrupt cessation of effective cardiac function that is generally due to heart rhythm disorders can cause sudden and unexpected death at any age and is referred to as a syndrome called "sudden cardiac death" (SCD). Annually, about 400,000 cases of SCD occur in the United States alone. Less than 5% of the resuscitation techniques are effective. The prevalence of SCD in a population rises with age according to the prevalence of coronary artery disease, which is the most common cause of sudden cardiac arrest. However, there is a peak in SCD incidence for the age below 5 years, which is equal to 17 cases per 100,000 of the population. This peak is due to congenital monogenic arrhythmic canalopathies. Despite their relative rarity, these cases are obviously the most tragic. The immediate causes, or mechanisms, of SCD are comprehensive. Generally, it is arrhythmic death due to ventricular tachyarrythmias - sustained ventricular tachycardia (VT) or ventricular fibrillation (VF). Bradyarrhythmias and pulseless electrical activity account for no more than 40% of all registered cardiac arrests, and they are more often the outcome of the abovementioned arrhythmias. Our current understanding of the mechanisms responsible for SCD has emerged from decades of basic science investigation into the normal electrophysiology of the heart, the molecular physiology of cardiac ion channels, the fundamental cellular and tissue events associated with cardiac arrhythmias, and the molecular genetics of monogenic disorders of the heart rhythm (for example, the long QT syndrome). This review presents an overview of the molecular and genetic basis of SCD in the long QT syndrome, Brugada syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia and idiopathic ventricular fibrillation, and arrhythmogenic right ventricular dysplasia, and sudden cardiac death prevention strategies by modern techniques (including implantable cardioverter-defibrillator).
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
09:20Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias I: Introduction
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy I: Introduction and Classification